A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis
NCT07355062
This study is recruiting at 24 US sites in 13 states, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this study is is to evaluate the efficacy and safety of veverimer in treating adults with moderate-to-severe chronic kidney disease (CKD) and metabolic acidosis.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- CKD
- Metabolic Acidosis
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 3
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Renibus Therapeutics, Inc.
- Last updated on ClinicalTrials.gov
- October 15, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 4
- Study Site · Chula Vista, CA
- Study Site · Los Angeles, CA
- Study Site · Sacramento, CA
- Study Site · San Diego, CA
Colorado · 1
- Study Site · Aurora, CO
Delaware · 1
- Study Site · Newark, DE
Florida · 4
- Study Site · Edgewater, FL
- Study Site · Margate, FL
- Study Site · Miami Springs, FL
- Study Site · Orlando, FL
Idaho · 3
- Study Site · Boise, ID
- Study Site · Chubbuck, ID
- Study Site · Idaho Falls, ID
Illinois · 1
- Study Site · Chicago, IL
Indiana · 1
- Study Site · Indianapolis, IN
Kentucky · 1
- Study Site · Louisville, KY
Michigan · 1
- Study Site · Pontiac, MI
Missouri · 1
- Study Site · Kansas City, MO
New York · 2
- Study Site · Fresh Meadows, NY
- Study Site · New York, NY
North Carolina · 1
- Study Site · Winston-Salem, NC
Texas · 3
- Study Site · Fort Worth, TX
- Study Site · Houston, TX
- Study Site · San Antonio, TX
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.